8th November 2022
- 0 comments
A company based at Queen’s University, Belfast which has developed a potentially life-saving new cancer treatment is to invest almost £8m to take its first anti-cancer drug through a first-in-human, Phase 1a clinical trial and perform further scientific development work.
...Register / Login now to read full story
In order to read the full story we need you to be registered with us, please click the links below to login or register.
Back to Homepage